{
    "ticker": "PULS",
    "name": "Pulse Biosciences, Inc.",
    "description": "Pulse Biosciences, Inc. is a medical technology company dedicated to advancing the field of bioelectric medicine through its proprietary technology platform, the Nano-Pulse Stimulation (NPS). Founded in 2016 and headquartered in Hayward, California, Pulse Biosciences aims to revolutionize the treatment of various medical conditions, including dermatological and oncological applications. The NPS technology utilizes electrical pulses to stimulate cellular responses without causing thermal damage, offering a novel, non-invasive alternative to traditional therapies. Pulse Biosciences is particularly focused on developing its flagship product for the treatment of skin lesions and tumors, with early studies demonstrating promising results in safety and efficacy. The company's mission is to enhance the quality of life for patients by providing innovative, effective, and safe treatment options. With a growing portfolio of patents and ongoing clinical trials, Pulse Biosciences is positioned to become a leader in the field of bioelectric therapies, contributing to the future of healthcare.",
    "industry": [
        "Medical Technology",
        "Biotechnology"
    ],
    "headquarters": "Hayward, California, USA",
    "founded": "2016",
    "website": "https://www.pulsebiosciences.com",
    "ceo": "Darryl Sampson",
    "social_media": {
        "twitter": "https://twitter.com/PulseBiosci",
        "linkedin": "https://www.linkedin.com/company/pulse-biosciences/"
    },
    "investor_relations": "https://investors.pulsebiosciences.com",
    "key_executives": [
        {
            "name": "Darryl Sampson",
            "position": "CEO"
        },
        {
            "name": "J. Michael McMahon",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Medical Devices",
            "products": [
                "Nano-Pulse Stimulation System"
            ]
        }
    ],
    "seo": {
        "meta_title": "Pulse Biosciences, Inc. | Innovating Bioelectric Medicine",
        "meta_description": "Explore Pulse Biosciences, Inc., a leader in bioelectric medicine with innovative technologies like Nano-Pulse Stimulation. Discover our mission and products.",
        "keywords": [
            "Pulse Biosciences",
            "Bioelectric Medicine",
            "Nano-Pulse Stimulation",
            "Medical Technology",
            "Dermatology",
            "Oncology"
        ]
    },
    "faq": [
        {
            "question": "What is Pulse Biosciences known for?",
            "answer": "Pulse Biosciences is known for its proprietary Nano-Pulse Stimulation technology used in bioelectric medicine."
        },
        {
            "question": "Who is the CEO of Pulse Biosciences?",
            "answer": "Darryl Sampson is the CEO of Pulse Biosciences, Inc."
        },
        {
            "question": "Where is Pulse Biosciences headquartered?",
            "answer": "Pulse Biosciences is headquartered in Hayward, California, USA."
        },
        {
            "question": "What are Pulse Biosciences' main products?",
            "answer": "Pulse Biosciences' main product is the Nano-Pulse Stimulation System for medical treatments."
        },
        {
            "question": "When was Pulse Biosciences founded?",
            "answer": "Pulse Biosciences was founded in 2016."
        }
    ],
    "competitors": [
        "ISRG",
        "MDT",
        "ABMD"
    ],
    "related_stocks": [
        "AAPL",
        "GOOGL",
        "AMZN",
        "MSFT"
    ]
}